154 related articles for article (PubMed ID: 6687904)
1. Immunohistochemical study of substance P-like immunoreactivity in human thyroid and medullary carcinoma of the thyroid.
Kakudo K; Vacca LL
J Submicrosc Cytol; 1983 Apr; 15(2):563-8. PubMed ID: 6687904
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma.
Conlon JM; McGregor GP; Wallin G; Grimelius L; Thim L
Cancer Res; 1988 May; 48(9):2412-6. PubMed ID: 3258543
[TBL] [Abstract][Full Text] [Related]
5. Distribution of beta-endorphin immunoreactivity in normal human pituitary.
Mendelsohn G; D'Agostino R; Eggleston JC; Baylin SB
J Clin Invest; 1979 Jun; 63(6):1297-301. PubMed ID: 221539
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia.
Williams ED; Ponder BJ; Craig RK
Clin Endocrinol (Oxf); 1987 Jul; 27(1):107-14. PubMed ID: 3498562
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactive calcitonin in amyloid fibrils of medullary carcinoma of the thyroid gland. An immunogold staining technique.
Butler M; Khan S
Arch Pathol Lab Med; 1986 Jul; 110(7):647-9. PubMed ID: 2424399
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
[TBL] [Abstract][Full Text] [Related]
9. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
Henninger S; Schatz H; Stracke H; Wagner U; Kracht J
Acta Histochem; 1988; 83(1):51-6. PubMed ID: 2897752
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical localisation of katacalcin, a calcium-lowering hormone cleaved from the human calcitonin precursor.
Ali-Rachedi A; Varndell IM; Facer P; Hillyard CJ; Craig RK; MacIntyre I; Polak JM
J Clin Endocrinol Metab; 1983 Sep; 57(3):680-2. PubMed ID: 6348069
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms of calcitonin, calcitonin gene-related peptide, and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma.
Cote GJ; Gagel RF
Henry Ford Hosp Med J; 1987; 35(2-3):149-52. PubMed ID: 2891648
[No Abstract] [Full Text] [Related]
13. Gastrin-releasing peptide-like immunoreactivity in medullary thyroid carcinoma.
Ghatei MA; Springall DR; Nicholl CG; Polak JM; Bloom SR
Am J Clin Pathol; 1985 Nov; 84(5):581-6. PubMed ID: 4061381
[TBL] [Abstract][Full Text] [Related]
14. Distribution of calcitonin-containing parafollicular cells of the thyroid in patients with chronic lymphocytic thyroiditis: a clinical, pathological and immunohistochemical study.
Lukács G; Sápy Z; Gyóry F; Tóth V; Balázs G
Acta Chir Hung; 1997; 36(1-4):204-6. PubMed ID: 9408347
[TBL] [Abstract][Full Text] [Related]
15. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
Mendelsohn G; Wells SA; Baylin SB
Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
[TBL] [Abstract][Full Text] [Related]
16. [Medullary carcinoma of the thyroid gland. Clinico-pathologic and immunohistochemical study].
Elsner B; De Marco L; López S; Curutchet HP
Medicina (B Aires); 1983; 43(3):263-70. PubMed ID: 6369069
[No Abstract] [Full Text] [Related]
17. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
18. [Calcitonin levels in tissue culture of thyroid medullary carcinoma].
Martin RC; Ezabella MC; Toledo SP
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(5):220-2. PubMed ID: 3836475
[No Abstract] [Full Text] [Related]
19. Calcitonin and somatostatin containing C cells in rat and human thyroid. Immunohistochemical study by a double-staining method.
Fierabracci A; Castagna M; Baschieri L
Pathologica; 1993; 85(1099):467-74. PubMed ID: 7510386
[TBL] [Abstract][Full Text] [Related]
20. [Value of immunohistochemistry in the study of medullary cancer of the thyroid. Implications of the results for the concept of the APUD system and of apudomas].
Caillou B; Rougier P; Schlumberger M; Talbot M; Parmentier C
Bull Cancer; 1984; 71(2):140-4. PubMed ID: 6145461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
